Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
a study on Inflammatory Bowel Disease
Ulcerative Colitis ASUC Infliximab Optimal Dose Optimal Frequency Theraputic Drug Monitoring Colitis Colitis, Ulcerative Ulcer
Lead Scientist at UCSD
- William Sandborn
Chief, Gastroenterology. Authored (or co-authored) 810 research publications.
- accepting new patients
- Start Date
- Completion Date
- Robarts Clinical Trials Inc.
- Study Type
- Last Updated